doi: 10.3389/fimmu.2024.1461756 Received 09 July 2024 Accepted 02 September 2024 Published 23 September 2024 Volume 15 - 2024 Edited by Yuekang Xu, Anhui Normal University, China Reviewed by Sadiq Umar, University of Illinois Chicago, United States Bettina Grtsch, University of Erlangen Nuremberg, Germany Updates Copyright 2024 Han, Liu, He, Han and Li
What the FDA Label and Guideline Documents Say The FDA prescribing information for evolocumab explicitly states: "Evolocumab is a human monoclonal antibody and is not expected to be metabolized by cytochrome P450 enzymes
For younger men who might want children in the future, or for those who prefer a more natural approach to hormone optimization, HCG monotherapy presents an option worth discussing with healthcare providers
A study in healthy older adults showed that supplementing with GlyNAC led to improvements in strength, gait speed, and body composition
& Patton, E